Wararka Warshadaha
Waxtarka muddada-dheer ee CD19 CAR T-Cell Therapy marka lagu daweynayo soo noqnoqoshada/dib-u-soo-celinta kansarka dhiigga ee Lymphoblastic
Daraasad horudhac ah ayaa muujinaysa guusha muddada dheer ee CD19 CAR T-therapy ee daaweynta bukaannada qaba dib-u-soo-kabashada / dib-u-celinta lymfoblastic leukemia (ALL) ka dib tallaalka unugyada unugyada unugyada unugyada unugyada dhiigga cas, oo bixiya rajo cusub oo ku saabsan hematology.
Horumarka Horumarka ee Unugyada Dilaaga Dabiiciga ah (NK) ee ka badan 50 sano
Shantii sano ee la soo dhaafay, cilmi baaris lagu sameeyay unugyada Killer ee Dabiiciga ah (NK) ayaa wax ka beddelay fahamkayaga difaaca jirka, iyadoo bixinaysa wadooyin cusub oo rajo ah oo loogu talagalay kansarka iyo daaweynta fayraska.
Horumarka Cudurrada Isgaadhsiinta Carruurta: Daaweynta Unug ee CAR-T waxay daaweysaa Bukaanka Lupus
Daraasad horudhac ah oo lagu sameeyay Isbitaalka Jaamacadda Erlangen ayaa si guul leh u daweysay gabar 16 jir ah oo qaba nidaamka lupus erythematosus (SLE) oo daran iyadoo la adeegsanayo daawaynta unugyada CAR-T. Tani waxay calaamad u tahay isticmaalka ugu horreeya ee daaweyntan ee lupus carruurta, taasoo rajo cusub siinaysa carruurta qaba cudurrada difaaca jirka.
Kobcinta Waxtarka PROTAC: Daraasad salka ku haysa
Daraasad dhowaan lagu sameeyay Isgaadhsiinta Dabeecadda ayaa daaha ka qaadaysa fikradaha muhiimka ah ee waddooyinka calaamadaynta ee wax ka beddelaya waxtarka burburinta borotiinka ee la beegsaday iyadoo la adeegsanayo PROTACs. Daahfurkaani wuxuu u gogol xaarayaa daawaynta waxtarka leh ee kansarka iyo cudurada kale.
Horumarinta Caafimaadka iyo Soo kabashada: Daryeelka Maalinlaha ah ee Bukaanka Leukemia
Xaqiijinta waayo-aragnimada daawaynta ee badbaadada iyo raaxada leh ee bukaanka leukemia waxay ku lug leedahay daryeel maalinle ah oo taxadar leh, oo ay ku jiraan nadaafadda deegaanka, nadaafadda shakhsi ahaaneed, nafaqada, iyo jimicsiga habboon. Hagahan waxa uu bixiyaa tabo lagama maarmaan u ah daryeel maalmeed wax ku ool ah si loo taageero soo kabashada.
Natiijooyinka Gogoldhigga ee CD7-Daawaynta CAR-T ee loogu talagalay T-ALL iyo T-LBL
Daraasad dhowaan la sameeyay ayaa iftiimisay natiijooyinka rajo-gelinta ah ee CD7-bartilmaameedka daawaynta unugyada antigen-ka (CAR) T ee lagu daweynayo bukaannada qaba soo noqoshada ama dib-u-celinta T-cell lymphoblastic leukemia (T-ALL) iyo T-cell lymphoblastic lymphoma (T-LBL).
Daboolista Shirka Sannadlaha ah ee ASH 2024 iyo Bandhigga
Kulanka Sannadlaha ah ee 66aad ee Bulshada Maraykanka ee Dhiig-baxa (ASH) ayaa la qaban doonaa laga bilaabo Disembar 7-10, 2024, Xarunta Shirarka San Diego, oo soo bandhigaysa cilmi-baaris hor-u-dhac ah iyo horumarinta dhiigga.
Rajo cusub oo laga qabo daawaynta Kansarka: Daaweynta TILs waxay u soo baxdaa sidii hore ee xiga
In kasta oo ay jiraan caqabadaha socda ee xagga warshadaynta iyo ganacsi-abuurka, xaddidaadaha daawaynta CAR-T waxa lagu xalliyaa hab cusub oo rajo leh: daawaynta Tumor-Infiltrating Lymphocyte (TIL). Horumarkaani wuxuu ku bishaareynayaa waa cusub oo dagaalka lagula jiro burooyinka adag.
Daawaynta Unuggu ma yihiin Mustaqbalka Cudurrada Isgaadhsiinta?
Daawaynta kacaanka ee kansarka waxa kale oo laga yaabaa inay awoodo inay daweyso oo dib u dejiso nidaamka difaaca si ay u bixiso cafis wakhti dheer ah ama suurtogal ah xitaa inay daaweyso cudurada difaaca jirka qaarkood.
